We are live on
!
Find out more
BioMarin Pharmaceuticals
BMRN
BMRN
414 hedge funds and large institutions have $14B invested in BioMarin Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 159 increasing their positions, 150 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
98.49% more ownership
Funds ownership: 0% → 98.49% (+98%)
6% more repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 150
0% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 57
5% less call options, than puts
Call options by funds: $90.6M | Put options by funds: $95.7M
2% less funds holding
Funds holding: 422 → 414 (-8)
9% less capital invested
Capital invested by funds: $15.4B → $14B (-$1.35B)
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
Holders
414
Holders Change
-8
Holders Change %
-1.9%
% of All Funds
10.35%
Holding in Top 10
11
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-15.38%
% of All Funds
0.28%
New
57
Increased
159
Reduced
150
Closed
57
Calls
$90.6M
Puts
$95.7M
Net Calls
-$5.06M
Net Calls Change
-$8.09M
Top Buyers
| 1 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$162M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$84M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$78.1M |
| 4 |
Primecap Management
Pasadena,
California
|
+$66.9M |
| 5 |
HM
HealthCor Management
New York
|
+$66.6M |
